Status:
COMPLETED
Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients
Lead Sponsor:
Yonsei University
Conditions:
Tuberculosis
Eligibility:
All Genders
20+ years
Brief Summary
For diagnosis of active tuberculosis, interferon-γ release assay based mycobacterium tuberculosis specific antigen may show higher sensitivity than tuberculin skin test in immunocompromised patients. ...
Eligibility Criteria
Inclusion
- Patient suspicious of active tuberculosis with immunocompromised condition
- Immunocompromised condition patients with
- solid cancer with chemotherapy
- hematologic malignancy
- organ transplantation
- immunosuppressant
- ESRD on renal replacement therapy
- diabetes
- advanced liver cirrhosis
Exclusion
- Patients with
- less than 20 years
- who don't agree the participation of study
- hypersensitivity history to tuberculin
- pregnancy
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00962676
Start Date
July 1 2009
End Date
December 1 2010
Last Update
February 2 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei Univ.
Seoul, South Korea